Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN120923522A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel cobalt catalyst enables asymmetric hydroboration of mixed olefins. Delivers high enantioselectivity and substantial cost reduction in pharmaceutical intermediates manufacturing.